Plain-English translation of NCT07488247 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This study is testing a treatment called Chlorin E6 gel combined with red light therapy (photodynamic therapy) for people with diabetic foot ulcers. The gel is applied to the wound, and after 30 minutes, a special red light is shone on the area for about 11 minutes. Researchers want to see if this treatment, used alongside standard wound care, helps ulcers heal faster and reduces the need for amputation.
Diabetic foot ulcers are a serious complication that can lead to infection and amputation. While standard wound care helps, many ulcers heal slowly or don't heal well, so researchers are testing whether this medication combined with light therapy could improve healing rates and prevent amputations.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will be randomly assigned to receive either the new gel and light treatment plus standard wound care, or standard wound care alone. Over 6 months, you will visit the study center regularly for wound assessments, photographs, and blood tests to track how well your ulcer is healing. The gel and light treatment, when used, takes about 45 minutes total per session (including application, waiting time, and light exposure).
AI-generated summary from trial data · Jul 4, 2026 · Not medical advice
Pakistan